Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Evoke Pharma Inc
EVOKCurrent price
3.82 USD
-0.003 USD (-0.08%)
Last closed
3.85 USD
Company
www.evokepharma.com
ISIN
US30049G2030
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
6 818 557 USD
Yield for 12 month
-48.66 %
1Y
3Y
5Y
10Y
15Y
EVOK
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18.00 USDP/E ratio
–Dividend Yield
–Current Year
+5 180 630 USD
Last Year
+2 508 645 USD
Current Quarter
+2 654 186 USD
Last Quarter
+2 551 366 USD
Current Year
+4 978 751 USD
Last Year
+2 138 251 USD
Current Quarter
+2 550 162 USD
Last Quarter
+2 509 888 USD
Key Figures EVOK
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-33.50 %
PEG Ratio
-0.10
Return On Equity TTM
-349.91 %
Wall Street Target Price
18.00 USD
Revenue TTM
8 617 036 USD
Book Value
4.90 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
69.80 %
Dividend Yield
–
Gross Profit TTM
2 138 251 USD
Earnings per share
-10.13 USD
Diluted Eps TTM
-10.13 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-71.33 %
Dividend Analytics EVOK
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History EVOK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
01.08.2024
Stock Valuation EVOK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.056
Price Sales TTM
0.79
Enterprise Value EBITDA
-0.36
Price Book MRQ
1.55
Financials EVOK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EVOK
For 52 weeks
3.54 USD
14.40 USD
50 Day MA
5.02 USD
Shares Short Prior Month
16 990
200 Day MA
5.68 USD
Short Ratio
0.24
Shares Short
25 129
Short Percent
1.70 %
BeatStart